Navigation Links
Summit of osteoporosis experts from CIS countries issue 5-point call for action
Date:1/9/2013

hat osteoporosis has been recognized as a priority for health care systems in CIS countries.

New epidemiological study underway:

The governments of CIS and adjacent countries do not draw enough attention to the problem. Despite evidence that fractures resulting from osteoporosis pose a major public health burden, neither epidemiological nor health-economic studies that might encourage specialists to be engaged in prevention are being carried out.

In many countries there is still a complete lack of relevant statistics. That is why the Russian Association on Osteoporosis has initiated the multinational population-based study in the countries of the region "Epidemiological study of osteoporotic fractures in Eurasia (EVA)". The goal is to obtain the data on incidence of main osteoporotic fractures.

Summit participants sign Appeal requesting action:

Given the dire state of affairs, the participants of the Summit proposed that osteoporosis be recognized as a health priority at the state level, and that treatment and prevention strategies, as well as urgent surgical treatment for patients with hip fractures, be provided. An appeal with such proposals towards the governments and health ministries of CIS countries was signed by the summit participants presenting 10 countries.

The signed document calls for the following five measures to be taken:

  • Recognize osteoporosis as a socially important disease due to high incidence, socio-economic burden and medical consequences;

  • Organize the collection of official statistics on fragility fractures, including hip fractures;

  • Increase the proportion of patients with hip fractures who can get surgical care within the first days after the trauma this will reduce the high rate of mortality and disability;

  • Provide the population with widely available DXA and modern methods of treatment of osteoporosis, free of charge for pe
    '/>"/>

Contact: L. Misteli
info@iofbonehealth.org
41-229-940-100
International Osteoporosis Foundation
Source:Eurekalert

0

GOOD

Page: 1 2 3 4 5

Related biology news :

1. Maya Angelou Center Brings International Women’s Health Summit to Winston-Salem, NC
2. 2012 American Chestnut Summit
3. Silicon Valley Energy Summit 2012
4. Validity CTO to Present Natural ID Solutions for Improving Mobile Risk Management and User Experience at NFC Solutions Summit 2012
5. IOF Asia-Pacific Meeting presents new research and advances in osteoporosis management
6. Launch of the EU large-scale integrating project BlueGenics to combat osteoporosis
7. Register now for the key osteoporosis meeting in the Asia-Pacific region
8. Dual action polyclonal antibody may offer more effective, safer protection against osteoporosis
9. Mechanisms for a beneficial effect of moderate alcohol consumption on osteoporosis in women
10. New review outlines screening strategies for osteoporosis in young adults
11. Progress in Osteoporosis re-launched with new design, now invites commentary
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... of all types become most deadly when they metastasize ... reached this stage, it becomes very difficult for doctors ... develop. Now, researchers at the University of Missouri have ... lymphoma tumor cells wherever they may be in the ... the MU College of Veterinary Medicine, says being able ...
(Date:5/21/2013)... The American Chemical Society (ACS), the world,s largest ... 246th National Meeting & Exposition, September 8-12, 2013, ... the Indiana Convention Center and at area hotels. ... discoveries that span science,s horizons from astronomy ... broadcast and online journalists a rich assortment of ...
(Date:5/21/2013)... genes function without changing the underlying DNA sequence, ... pregnant women during any trimester, potentially providing a ... after giving birth, and an opportunity to intervene ... the small study involving 52 pregnant women are ... . , "Postpartum depression can be harmful to ...
Breaking Biology News(10 mins):MU researchers develop radioactive nanoparticles that target cancer cells 2Genetic predictors of postpartum depression uncovered by Hopkins researchers 2Genetic predictors of postpartum depression uncovered by Hopkins researchers 3
... small biotech company in Boulder, CO, announced today that they ... The FluChip was invented by a joint team of ... Disease Control and Prevention in an NIH sponsored effort led ... CEO of InDevR, said that InDevR has arranged to test ...
... grants totaling $24 million in U.S. dollars have ... hospitals to fund studies related to asthma and ... cancer. The extramural grants were awarded by ... for Science, Technology and Research), the government agency ...
... The Entomological Society of America (ESA) will feature ... Meeting in Indianapolis, December 13-16, 2009. Integrative ... Cold Case Files: Integrative Perspectives on Physiological ... Evolutionary Arms Race of Resistance in Herbivores ...
Cached Biology News:FluChip technology licensed to combat deadly flu virus 2Alzheimer's, asthma, cancer, malaria and TB focus of new Singapore grants 2Alzheimer's, asthma, cancer, malaria and TB focus of new Singapore grants 3Alzheimer's, asthma, cancer, malaria and TB focus of new Singapore grants 4Symposia selected for Entomological Society of America meeting 2Symposia selected for Entomological Society of America meeting 3Symposia selected for Entomological Society of America meeting 4
(Date:5/21/2013)... of a new study led by George Washington ... that nucleation of ice in small droplets is ... behavior at the nanoscale. The formation of ice ... research question whose answer also has important implications ... The crystallization of ice from supercooled water is ...
(Date:5/21/2013)... , May 21, 2013 The ... and Transplant Association) is the biggest congress in ... therapy. Nearly 10,000 participants are in Istanbul ... latest research findings. New pioneering studies have been presented: ... FERRIC PYROPHOSPHATE (SFP) ADMINISTERED VIA HEMODIALYSATE REDUCES ESA USE" ...
(Date:5/21/2013)... 21, 2013 Clinverse, Inc. ... for clinical trials, announced today it has formed ... Clinverse’s ClinPay® FLS eClinical commerce platform aggregates ... SpendMD ™, Aggregate Spend Solutions’ recently-launched ... tracking and reporting transfer of value at investigator ...
(Date:5/21/2013)... ALBANY, New York , May 21, 2013 /PRNewswire/ ... published by Transparency Market Research ( http://www.transparencymarketresearch.com ) "Biochip ... Science Research, IVD Tests) - U.S. Industry Analysis, Size, Share, ... USD 2.4 billion in 2011 and is expected to ... 2018, to reach an estimated value of USD 4.7 ...
Breaking Biology Technology:Study led by GW professor provides better understanding of water's freezing behavior at nanoscale 2ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials 2ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials 3Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 2The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 4The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 5
... China, May 14 Simcere Pharmaceutical,Group (NYSE: SCR ), ... of the patented anti-cancer biotech,product Endu in China, today announced ... conferences:, * Brean Murray Carret & Co. ... Waldorf-Astoria in New York on Monday, May 19, 2008 at ...
... 14 SynCo Bio Partners B.V., a leading,GMP ... manufacture and release of ActoGeniX, drug substance AG011 ... ulcerative colitis patients., ActoGeniX is focused on ... of protein-based biopharmaceuticals that can,be orally administered. The ...
... CITY, New Jersey, May 14, Rosetta Genomics (Nasdaq: ... results on May 21, 2008, before the,U.S. markets open. ... webcast to discuss these results at 4:30 p.m. ET ... call, U.S. and Canadian participants may,dial +1-866-966-5335; international participants ...
Cached Biology Technology:Simcere Pharmaceutical Group to Participate in Upcoming Investor Conferences in New York 2SynCo Bio Partners Completes Manufacture and Release of ActoGeniX' Lead Product for Phase II Clinical Trials 2SynCo Bio Partners Completes Manufacture and Release of ActoGeniX' Lead Product for Phase II Clinical Trials 3Rosetta Genomics Announces Conference Call and Webcast of First Quarter Financial Results 2
... Magnetofection technology, SilenceMag is the most ... rapid and easy to use, SilenceMag ... Specifically designed for siRNA delivery, SilenceMag ... low doses of siRNA.,SilenceMag formulation gives ...
... Last innovation from Magnetofection technology, SilenceMag ... system available. Simple, rapid and easy ... and non toxic. Specifically designed for ... silencing at very low doses of ...
... 4 H 10 O 2 S ... SPECIFICATIONS Form: White crystalline powder Assay: ... Identity: By IR Melting Point: greater ... DTT: less than or equal to ...
... Software reads and processes raw ... microarray data for analysis. ... one 2-year license for Feature ... , * one CD-ROM ...
Biology Products: